Quantum AI blood test could revolutionize prostate cancer screening

NCT ID NCT07238959

Summary

This study is testing a new blood test that uses advanced quantum sensors and artificial intelligence to detect prostate cancer early. It aims to help doctors diagnose cancer more accurately without needing as many invasive biopsies. The test will be studied in about 1,100 men who already need a prostate biopsy due to elevated PSA levels or other concerning signs.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE HYPERTROPHY(BPH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Hospital, Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, 100021, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Jiangsu Provincial People's Hospital

    Nanjing, Jiangsu, China

  • Ningbo No. 1 Hospital

    Ningbo, Zhejiang, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shanghai Changzheng Hospital

    Shanghai, Shanghai Municipality, 201209, China

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, 510120, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • West China Hospital, Sichuan University

    Chengdu, Sichuan, 610041, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.